ãèªç±è¨ºçå»åä½ãé«æ¿åº¦ãã¿ãã³Cçæ³ã®ã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ãåºã¦ããã®ã§ã確èªä¸ãããã
Â
å¤ãã®èªç±è¨ºçç³»ã®ã¯ãªããã¯ã§ã¯ããã®æããä½ç¨ãQOLï¼quality of lifeï¼æ¹åä½ç¨ã謳ãæå¥ã¨ãã¦ãããæ£è ããã«ãé«æ¿åº¦ãã¿ãã³Cçæ³ããæä¾ãã¦ãã¾ãããã®æ²»çãåãã¦ããã£ãããæ£è ããã®å¿ã®ä¸ãæ³åããã«ããçå¾ãããããªããã©ãã¹ãæ£ã«é«ãããã§ããªãããå°ãªãã¨ã害ã¯ãªãããã ãã試ãã«åãã¦ã¿ããããã¨è¨ã£ãã¨ããã§ã¯ãªãã§ããããã
Â
ããããèªç±è¨ºççã®ãã³ã©ã¹ã»ã±ã¤ã¸ã¨ãå¼ã¹ããã®æ²»çæ³ã¯ãæ ¹æ ãã¨ã¦ãèããæããã«çã£ã¦ããã®ã§ã¯ãªãããã¨ããæççãªè¦æ¹ã大å¢ãå ãã¦ãã¾ãã
Â
2015年度ã«å ¥ããThe Oncologistèªã«ã5ã¤ã®ã©ã³ãã åæ¯è¼è©¦é¨ãå«ãç·å¢35è«æã8,563åã«ãåã¶æ£è ã対象ã¨ãã¦ããã¿ãã³Cã®æããä½ç¨ã«ã¤ãã¦è§£æãããã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ãæ²è¼ããã¾ããã
Â
ã·ã¹ãããã£ãã¯ã¬ãã¥ã¼ã¨ã¯ãããè¨åºççåã«å¯¾ãã¦æ¤è¨ãããå質ã®ç 究ãç¶²ç¾ çã«èª¿æ»ãçµ±åãã¦åæããç 究ææ³ã®ãã¨ã§ããåãç®çãæããè¨åºè©¦é¨ã§ããèæ¯ãè¨å®ãç°ãªãã°çµæãã¾ã¡ã¾ã¡ã«ãªããã¨ã¯å°ãªãããã¾ããããã®è¾ºãã®ãã¤ã¢ã¹ã極åæé¤ãã¦çµ±åãã¦ã¿ããã©ããªã®ããã¨ãããã¨ã§ãããã¡ãããã®ææ³èªä½ã«ãåé¡ç¹ã¯ããã¾ãããä¸å¿ã¨ããã³ã¹ã¬ãã«ã¨ãã¦ã¯æé«ä½ã§ãã
Â
ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼
Â
âIs There a Role for Oral or Intravenous Ascorbate (Vitamin C) in Treating Patients With Cancer? The Oncologist. 2015; 20; 210-223. â
Â
å ¨æããªã¼ãã¦ã³ãã¼ãå¯è½ãªã®ã§è©³ç´°ã¯è¨è¼ãã¾ããããçµè«é¨åã ãå¼ç¨ãã¦ããã¾ãã
Â
We have found no consistent evidence for an antitumor effect in terms of improved response rates or improved survival outcomes and also no evidence supporting an improvement in quality-of-life measures associated with ascorbate use in patients with malignancy in a controlled setting.
Â
ç°¡æ½ã«ç³ãä¸ããã°ãããã¿ãã³Cã«è¨åºçã«æå³ã®ããæããä½ç¨ãQOLæ¹åä½ç¨ããããã¨ãã証æ ãè¦ã¤ãããã¨ã¯ã§ãã¾ããã§ãããã¨ãªãã¾ããæ訳ããã°ããããæ£è ãããé«æ¿åº¦ãã¿ãã³Cçæ³ãåããã¡ãªããã¯ããã¨ã¯èãã«ãããã¨ãè¨ãã¾ãã
Â
==================================================
Â
ããããææã«ã¯å¿ ãåè«ãã¤ãã¾ãã
Â
ãæããä½ç¨ããã証æ ããªãã¦ããæããä½ç¨ããªã証æ ã«ã¯ãªããªãã
æªéã®è¨¼æã§ããããã¿ãã³Cã«æããä½ç¨ããããã¨ãã証æ ãè¦ã¤ãããã¨ã¯ã§ããªããã¨ããæã£ã¦åã£ãè¨ãåãã§ã¯ãªããããã¿ãã³Cã«ã¯æããä½ç¨ã¯ããã¾ãããã¨æ¯åãããè¨ãããã¨ãããªã®ã§ãããè¯å¿çãªå»çè ã§ããã°æè¨ã¯ããªããã®ã§ãããããä»ãè¾¼ã¾ããããã§ãããå»çè ããããæããä½ç¨ãå¦å®ããã¦ããªãæ²»çãã§ã¯ãªãããæããä½ç¨ã証æãããæ²»çãã§å»çãè¡ã£ã¦ãã ããã
Â
ãå®éã«è¯ããªã£ãæ£è ãããã
帰ç´ã§ããã©ã®ããã«è¯ããªã£ãã®ãï¼ä»ã®æ²»çãä½µç¨ãã¦ããªãã£ãã®ãï¼ãã®æ¹ã®ä»ã«æ²»çãåãã人ãä½äººãã¦ããã®ä¸ã§ä½äººãè¯ããªãä½äººãè¯ããªããªãã£ãã®ãï¼å人ã®ä½é¨è«ã¯æ ¹æ ã¨ãã¦ã¯æä½ã¬ãã«ã§ãã
Â
ãã¾ã¨ããªè©¦é¨ããªãã ãã§ãçã®è©ä¾¡ã«ã¯ãã£ã¨è³ªã®é«ã試é¨ãå¿ è¦ã ã
循ç°è«æ³ã¨è¨ããã§ãããããããã¾ã§ã®è¨åºè©¦é¨ã«ããæããå¤ã¨ãã¦ã®ãã¿ãã³Cã®ä¾¡å¤ã篩ã«æããã ãã®è³ªã¯ååã«ããããã§ããè«å¤§ãªè²»ç¨ã¨æéã¨ãã³ãã¯ã¼ãå¿ è¦ã¨ãã質ã®é«ãè¨åºè©¦é¨ã¯ãææãªæ²»çæ³ã«å®ããããã®ãæ®éã§ãã£ã¦ãæ¢ã«åç®ãç«ããªããªã£ããã¿ãã³Cã«ã¯æ´ã«æ¤è¨ããã ãã®ä¾¡å¤ãããã¾ãããããã§ããå®è¡ããå¿ è¦ãããã®ã§ããã°èªç±è¨ºçå»ãè¡ãã°ããã¨æãã¾ãã
Â
ãæããä½ç¨ãQOLæ¹åä½ç¨ããªãã¦ããæ£è ã«å¸æã¨æºè¶³æãä¸ãã¦ããã
è«ç¹ã®ããæ¿ãã§ããå¸æãæºè¶³æã¯ãã¡ãã大åãªè¦ç´ ã§ãããè«ç¹ã¯ãä½ãæ ¹æ ã«é«æ¿åº¦ãã¿ãã³Cãè¡ã£ã¦ããã®ãï¼ãã§ãããå¸æãæºè¶³åº¦ãè°è«ãã¦ããããã§ã¯ããã¾ããã
Â
ãæ¨æºæ²»çå»ããããèªç±è¨ºçå»ã®æ¹ã親身ã«ç¸è«ã«ä¹ã£ã¦ããã
人身æ»æã§ããç§å¦çå証ãé£ããã®ã§ãæ¹å¤è ã®æ 度ãæ»æããããã§ããæ 度ãä¸éãªå»çè ãå°ãªããªãã®ã¯äºå®ã§ããããã¯å¤§ãã«åçãã大ãã«æ¹åããåªåãããªãã¦ã¯ãªãã¾ãããããããèªç±è¨ºçå»ã«ã¨ã£ã¦ã®æ£è ããã¯ãæ£è ãã§ã¯ãªãã顧客ããªã®ã§ãèªãã¨æ¥å®¢ã«ãåãå ¥ããã¨ã§ããããæ¬å½ã«åªãã人ã¯åªãããã¨ã°ããè¨ãã¾ããã
Â
ãæããä½ç¨ã¯ãªãã¦ãããã®æé ¸åä½ç¨ãããããå©çã¾ã§å¥ªãã®ãï¼ã
è人形è«æ³ã¨è¨ããã§ãããããä»®ã«ä½æãã®å©çãããã¨ãã¦ãè¶ çµ¶çã«å¾®ã ãããã®ã§ããããã ãããããããã¾ã§ã®è¨åºè©¦é¨ã§ã¯ä½ãå¤æããªãã£ãã®ã§ããç©åã大è¦æ¨¡ã§ç©åã質ã®é«ã試é¨ãå®ç¾ã§ããã°ãä½æãã®å©çãå¤æããããããã¾ããããããã¯è²»ããããéã¨æéã«è¦åããã®ã§ããããï¼åããéã¨æéã§ããé£ã¹ãããã®ãé£ã¹ãè¡ãããã¨ããã«è¡ããéãããã人ã¨éãããã¨ããæ¹æ³ã§è²»ãããæ¹ããã£ã½ã©ææ義ã ã¨æãã¾ãã
Â
ãç§å¦çã«è¨¼æããã¦ããªãã¦ããå®éã«æããä½ç¨ãããç©è³ªã¯åå¨ããã¯ãã
åè«ã«ããªã£ã¦ãã¾ããããå ·ä½çã«ãç§å¦çã«è¨¼æããã¦ããªãããå®è¨åºã§æããä½ç¨ã¨ãã¦å©ç¨ããã¦ããè¬å¤ãã®ä¸ä¾ãæãã¦é ãããã®ç©è³ã¨ãã¿ãã³Cã®é¢é£æ§ã説æãã¦é ãå¿ è¦ãããã¾ãã
Â
ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼ï¼
Â
ä½åº¦ã¨ãªãææããããã¨ã§ã¯ããã¾ãããç§ãææãã¦ããã¾ãã
Â
ããããã¿ãã³Cãæ¬å½ã«æç¨ãªãã°ã製è¬ä¼ç¤¾ãå»çè ãæ¾ã£ã¦ããçç±ãããã¾ããããã®ä»ã®åå¦çæ³ã¨ã¯æ¯è¼ã«ãªããªãã»ã©å®å ¨æ§ãæ ä¿ãããã»ã¨ãã©ã®åå¦çæ³ã¨ã®ä½µç¨ãå¯è½ãªã®ã§ããããããã«æç¨æ§ãå ããã°ã¯ã£ããè¨ã£ã¦ç¡æµã§ããå»çè å´ããããã°ãã¾ããã¨ãããããã¿ãã³Cãä½µç¨ãã¦ããããã¨ãªãã§ããããä¼æ¥å´ãããã¦ãããã¨ãåã ã«ã¯å®ä¾¡ã§ãã£ã¦ããéè¦ã¯è¨å¤§ã§ä¼æ¥å©çãç¸å¿ã§ãããããé£ã³ä»ãã¯ãã§ããããããåãããçç¡ãã§ããæç¹ã§ãå¯ãä¸ãããã¨ãããã¨ãªã®ã§ãã
Â
ä½åº¦ã§ãç³ãä¸ãã¾ãããç§ãæ¹å¤ãã¦ããã®ã¯é«æ¿åº¦ãã¿ãã³Cçæ³ã§ã¯ãªããé«æ¿åº¦ãã¿ãã³Cçæ³ã§å売ããã¦ãã人ãã¡ã§ããæ ¹æ ã®ãªãæ²»çãæ ¹æ ãããããã«è¦ãããã¦æä¾ããã®ã¯è©æ¬ºã«çããè¡çºã§ãããèã«ããããæãã®äººã«èãæãã¤ããã®ã¯äººéçã«è¨±ããããè¡çºã§ãã
Â
æå¾ã«è³æ¥µå½ç¶ã®ãã¨ãè¨ã£ã¦ããã¾ããããã¿ãã³Cãæåããã¡ãªããããã人ã¯ããã¿ãã³Cãæ¬ ä¹ãã¦ãã人ã ããã§ããããããäºå®ã¯ä½åº¦ã§ãç¹°ãè¿ããä¼ããã¦ãããããªãã¨æãã¾ããé«æ¿åº¦ãã¿ãã³Cçæ³ã«ãéã¨æéãã¤ãè¾¼ãã§ãã¾ã人ãä¸äººã§ãæ¸ããã¨ãåã«é¡ã£ã¦ãã¾ãã
Â